News
Alina Holdings PLC: Interim Results for the period ended 30 June 2022
Travis Perkins plc - Half year results for the six months ended 30 June 2022
DGAP-News: Defence Therapeutics Inc.: BREAKTHROUGH DISCOVERY: ACCUTOXTM EFFECTIVELY KILLS CANCER CELLS BY DIRECTLY ELICITING DNA DAMAGE
DGAP-News: Elmos Semiconductor SE: Strong second quarter 2022 – further positive development expected in the second half of the year
DGAP-News: CENIT with a strong half-year result: Group revenues increase by 6.2% compared to previous year to EUR 73,912 k, EBIT increases by 19.5%
DGAP-News: SFC Energy secures several orders for EFOY Pro energy solutions from Oneberry Technologies amounting to a total of approximately EUR 2.0 million
DGAP-News: VIB Vermögen AG: VIB Vermögen increases gross rental income and doubles profit for the period
DGAP-News: CLIQ Digital announces 94% sales growth for the second quarter
Meyer Burger adjusts expected production volumes for 2022 and 2023
Implenia wins further large, complex real estate projects in western Switzerland
Interroll significantly increases sales in a difficult market environment
Schwab Repurchases $1 Billion of Shares Held by TD Bank Group
The Charles Schwab Corporation (“Schwab” or the “Company”) announced today that it has purchased approximately 15 million shares of its nonvoting common stock directly from TD Bank Group (“TD
Dexcom ONE real-time Continuous Glucose Monitoring (rt-CGM) System available on prescription in the UK, improving access to rt-CGM for people with diabetes
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, and NHS England today announced the availability of the easy to use Dexcom ONE
The First Bancshares, Inc. Completes Acquisition of Beach Bancorp, Inc.
The First Bancshares, Inc. (NASDAQ: FBMS) (“First Bancshares” or the “Company”), the holding company for The First Bank (“The First”), announced today that it has completed its acquisition of Beach
Institutional Property Advisors Brokers $91 Million Luxury Multifamily Asset Sale in Gilbert, Arizona
Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE:MMI), announced today the sale of The Wyatt, a 216-unit luxury multifamily asset in Gilbert, Arizona. The $91 million
Insperity Announces Strong Second Quarter Results
Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses, today reported results for the second quarter ended June 30
Navidea Biopharmaceuticals Announces Publication of Study Examining Use of Tc99m Tilmanocept for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Melanoma and Oral Cancer in Australia
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today
American States Water Company Announces Second Quarter 2022 Results
American States Water Company (NYSE:AWR) today reported basic and fully diluted earnings per share of $0.54 for the quarter ended June 30, 2022, as compared to basic and fully diluted earnings per
Douglas Emmett Releases Second Quarter 2022 Earnings Results
Douglas Emmett, Inc. (NYSE: DEI), a real estate investment trust (REIT), has released its Second Quarter 2022 Earnings Results and Operating Information package by posting it to the investor
American Equity Schedules Second Quarter 2022 Earnings Release, Conference Call and Webcast
American Equity Investment Life Holding Company (NYSE: AEL) announced today that it will release second quarter 2022 earnings and other financial results after the close of market on Monday, August
Annaly Capital Management, Inc. Announces Public Offering of Common Stock
Annaly Capital Management, Inc. (NYSE: NLY) (the “Company” or “Annaly”) today announced that it intends to make a public offering of 100,000,000 shares of its common stock.
In connection with the
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, announced that